scispace - formally typeset
V

V. S. Nadarajan

Researcher at University of Malaya

Publications -  37
Citations -  859

V. S. Nadarajan is an academic researcher from University of Malaya. The author has contributed to research in topics: Population & Imatinib mesylate. The author has an hindex of 11, co-authored 32 publications receiving 776 citations. Previous affiliations of V. S. Nadarajan include University Malaya Medical Centre.

Papers
More filters
Journal ArticleDOI

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.

TL;DR: The results offer an explanation for the heterogeneity of TKI responses across individuals and suggest the possibility of personalizing therapy with BH3 mimetics to overcome BIM-polymorphism–associated TKI resistance.
Journal ArticleDOI

Genetic polymorphisms of human platelet antigens-1 to -6, and -15 in the Malaysian population

TL;DR: The allele frequencies of HPA in Malays and Chinese were found to be similar those of other East and South-East Asian populations, while those of Indians were comparable to the frequencies found in Europeans.
Journal ArticleDOI

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders

TL;DR: A 60-year-old man who initially presented with phenotype of polycythemia vera, which evolved into chronic myeloid leukemia and back to PV once treatment with imatinib was commenced, implies that two independent clones exist with the JAK2 V617F clone only achieving clonal dominance when BCR-ABL positive clones are suppressed by imatinIB.
Journal Article

Anaemia and iron status among blood donors in a blood transfusion unit in Malaysia

TL;DR: It is concluded that a high prevalence of iron deficiency is present among regular male blood donors and all female donors and the use of the copper sulphate screening test as a sole criterion for anaemia screening should be reviewed.
Journal ArticleDOI

Use of red blood cell indices for the identification of iron deficiency among blood donors

TL;DR: The parameter RBC‐Y can be useful as a screening measure for iron deficiency in blood donors, and compare favourably with haemoglobin which only showed a sensitivity of 50%, although specificity was 91% at a cut‐off value of 125 g L−1.